Wondering how to use Hookipa in a sentence? Below are 3 example sentences from authentic English texts. .
Hookipa in a sentence
Context around Hookipa
- Average sentence length in these examples: 29.7 words
- Position in the sentence: 3 start, 0 middle, 0 end
- Sentence types: 3 statements, 0 questions, 0 exclamations
Corpus analysis for Hookipa
- In this selection, "hookipa" usually appears near the start of the sentence. The average example has 29.7 words, and this corpus slice is mostly made up of statements.
- Recognizable usage signals include hookipa s board and hookipa s off. That gives this page its own corpus information beyond isolated example sentences.
- By corpus frequency, "hookipa" sits close to words such as aaaaand, aaah and aacl, which helps place it inside the broader word index.
Example types with hookipa
The same corpus examples are grouped by length and sentence type, making it easier to see the contexts in which the word appears:
HOOKIPA’s “off-the-shelf” viral vectors target dendritic cells in vivo to activate the immune system. (17 words)
HOOKIPA’s proprietary arenavirus-based technologies, VaxWave, a replication-deficient viral vector, and TheraT, a replication-attenuated viral vector, are designed to induce robust antigen specific CD8 T cells and pathogen-neutralizing antibodies. (33 words)
HOOKIPA’s Board of Directors will now consist of 8 members, including Dr. Jan van de Winkel as Chairman, Michael A. Kelly, Dr. David R. Kaufman, Dr. Christoph Lengauer, Julie O’Neill, Graziano Seghezzi, Joern Aldag, and Reinhard Kandera. (39 words)
HOOKIPA’s Board of Directors will now consist of 8 members, including Dr. Jan van de Winkel as Chairman, Michael A. Kelly, Dr. David R. Kaufman, Dr. Christoph Lengauer, Julie O’Neill, Graziano Seghezzi, Joern Aldag, and Reinhard Kandera. (39 words)
HOOKIPA’s proprietary arenavirus-based technologies, VaxWave, a replication-deficient viral vector, and TheraT, a replication-attenuated viral vector, are designed to induce robust antigen specific CD8 T cells and pathogen-neutralizing antibodies. (33 words)
HOOKIPA’s “off-the-shelf” viral vectors target dendritic cells in vivo to activate the immune system. (17 words)
Example sentences (3)
HOOKIPA’s Board of Directors will now consist of 8 members, including Dr. Jan van de Winkel as Chairman, Michael A. Kelly, Dr. David R. Kaufman, Dr. Christoph Lengauer, Julie O’Neill, Graziano Seghezzi, Joern Aldag, and Reinhard Kandera.
HOOKIPA’s “off-the-shelf” viral vectors target dendritic cells in vivo to activate the immune system.
HOOKIPA’s proprietary arenavirus-based technologies, VaxWave, a replication-deficient viral vector, and TheraT, a replication-attenuated viral vector, are designed to induce robust antigen specific CD8 T cells and pathogen-neutralizing antibodies.